NCAM1 and plasma cell leukemia: Importantly, PIII-15 also bound to CD138+ malignant plasma cells of a PCL patient, whereas no reactivity was observed with CD3+ T lymphocytes and CD56+ cells (predominantly NK cells) of an healthy individual (Figure 1E).